aegerion pharmaceuticals inc
(AEGR:Consolidated Issue Listed on NASDAQ Global Select )
Frank M. Sacks M.D.
Member of Scientific Advisory Board,Aegerion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Frank Sacks MD serves as a Member of Scientific Advisory Board at Aegerion Pharmaceuticals, Inc. Dr. Sacks serves as the Chair of the Steering Committee for the National Heart, Lung and Blood Institute's, or NHLBI's, Dietary Approaches to Stop Hypertension-Sodium trial, the Co-Chair of the Optimal Macronutrient Intake Trial to Prevent Heart Disease and the Principal Investigator of an NHBLI trial researching the dietary approaches for weight loss and maintenance. ...
One Main StreetPhone: 617-500-7867
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|$1.5M||Compensation as of Fiscal Year 2014.|